However, in the Chinese population that we evaluated, we failed to replicate the significant findings between polymorphisms in HIF1A[8] as well as EPAS1[9] and the risk of RCC, which indicates that there are differences in the genetic architecture of ethnic groups, and investigating the genetic variations in other candidate genes is still necessary. This evidence concerns the gene EPAS1 and renal cell adenocarcinoma.